Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Tan

Showing results (271-280 of 317) with videos related to

Pageof 32
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 12, 2025
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancerStephanie P L Saw, Wen-Zhao Zhong, Rui Fu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSK Park, J Vansteenkiste, K H Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2025
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancerStephanie P L Saw, Angela Takano, Siqin Zhou, et al.
Biomaterials|June 14, 2019
Hepatic spheroids used as an in vitro model to study malaria relapseAdeline C Y Chua, Abhishek Ananthanarayanan, Jessica Jie Ying Ong, et al.
Science Advances|January 21, 2026
A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC)Yafei Du, Wenjing Wang, Hui Chin Goh, et al.
JAMA Network Open|November 5, 2021
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung CancerStephanie P L Saw, Siqin Zhou, Jianbin Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 10, 2018
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLCChristian Rolfo, Philip C Mack, Giorgio V Scagliotti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancerStephanie P L Saw, Win Pin Ng, Siqin Zhou, et al.
The Lancet. Oncology|October 3, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trialJürgen Wolf, Maximilian Hochmair, Ji-Youn Han, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
Pageof 32

Showing results (271-280 of 317) with videos related to

Sort By:
Pageof 32
Lung Cancer (Amsterdam, Netherlands)|January 12, 2025
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancerStephanie P L Saw, Wen-Zhao Zhong, Rui Fu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSK Park, J Vansteenkiste, K H Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2025
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancerStephanie P L Saw, Angela Takano, Siqin Zhou, et al.
Biomaterials|June 14, 2019
Hepatic spheroids used as an in vitro model to study malaria relapseAdeline C Y Chua, Abhishek Ananthanarayanan, Jessica Jie Ying Ong, et al.
Science Advances|January 21, 2026
A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC)Yafei Du, Wenjing Wang, Hui Chin Goh, et al.
JAMA Network Open|November 5, 2021
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung CancerStephanie P L Saw, Siqin Zhou, Jianbin Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 10, 2018
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLCChristian Rolfo, Philip C Mack, Giorgio V Scagliotti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancerStephanie P L Saw, Win Pin Ng, Siqin Zhou, et al.
The Lancet. Oncology|October 3, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trialJürgen Wolf, Maximilian Hochmair, Ji-Youn Han, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
Pageof 32